Skip to main content
Top
Published in: Virchows Archiv 5/2008

Open Access 01-05-2008 | Original Article

Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas

Authors: Hua-chuan Zheng, Xiao-han Li, Takuo Hara, Shinji Masuda, Xiang-hong Yang, Yi-fu Guan, Yasuo Takano

Published in: Virchows Archiv | Issue 5/2008

Login to get access

Abstract

To investigate the pathobiological behaviors of gastric mixed-type (MT) carcinomas and gastric carcinogenesis, the clinicopathological characteristics of MT carcinomas were analyzed and compared with intestinal-type (IT) and diffuse-type (DT) carcinomas. The expression of Ki-67, caspase-3, p53, fragile histine triad (FHIT), maspin, extracellular matrix metalloproteinase inducer (EMMPRIN), vascular growth factor (VEGF), MUC-2, 4, 5AC and 6, CD44, E-cadherin, β-catenin, and phosphorylated glycogen synthase kinase 3β-ser9 (P-GSK3β-ser9) was examined on tissue microarrays using immunohistochemistry. It was found that MT carcinomas exhibited large size, deep invasion, frequent local invasion, and lymph node metastasis in comparison with IT and DT carcinomas (p < 0.05). All the markers except MUC-5AC showed higher expression in IT than DT carcinomas (p < 0.05). The expression of maspin, EMMPRIN, VEGF, MUC-4, and membrane E-cadherin was stronger in MT intestinal than diffuse component (p < 0.05). Immunoreactivities to Ki-67, EMMPRIN, and VEGF were weaker in IT carcinoma than in the MT intestinal portion (p < 0.05), while the opposite was true for CD44, MUC-2, and MUC-6 (p < 0.05). The MT diffuse component displayed a higher expression of FHIT, VEGF, and P-GSK3β-ser9 than DT carcinoma (p < 0.05). The accumulative survival rate of the IT carcinoma patients was higher than the other types (p < 0.05). The invasive depth, venous invasion, lymph node, peritoneal or liver metastasis, and Lauren's classification were independent prognostic factors for gastric carcinomas (p < 0.05). These findings suggested that MT carcinomas were also indicated to be more aggressive than IT and DT carcinomas. Significant differences were observed in the proliferation, apoptosis, angiogenesis, mucin secretion, and cell adhesion between IT and DT carcinomas, whereas only a few of these characteristics showed differences between the MT intestinal and diffuse parts, thus suggesting that both the MT components might originate from the stem cells with similar genetic traits, but follow different histogenic pathways.
Literature
1.
go back to reference Ali A, Hoeflich KP, Woodgett JR (2001) Glycogen synthase kinase-3: properties, functions, and regulation. Chem Rev 101:2527–2540PubMedCrossRef Ali A, Hoeflich KP, Woodgett JR (2001) Glycogen synthase kinase-3: properties, functions, and regulation. Chem Rev 101:2527–2540PubMedCrossRef
2.
go back to reference Borch K, Jonsson B, Tarpila E, Franzen T, Berglund J, Kullman E, Franzen L (2000) Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma. Br J Surg 87:618–626PubMedCrossRef Borch K, Jonsson B, Tarpila E, Franzen T, Berglund J, Kullman E, Franzen L (2000) Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma. Br J Surg 87:618–626PubMedCrossRef
3.
go back to reference Byrd JC, Bresalier RS (2004) Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 23:77–99PubMedCrossRef Byrd JC, Bresalier RS (2004) Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 23:77–99PubMedCrossRef
4.
go back to reference Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P, Caldas C, Sobrinho-Simões M (2004) Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 203:681–687PubMedCrossRef Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P, Caldas C, Sobrinho-Simões M (2004) Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 203:681–687PubMedCrossRef
5.
go back to reference Carneiro F, Seixas M, Sobrinho-Simoes M (1995) New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract 191:571–584PubMed Carneiro F, Seixas M, Sobrinho-Simoes M (1995) New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract 191:571–584PubMed
6.
go back to reference Esaki Y, Hirayama R, Hirokawa K (1990) A comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer 65:2086–2090PubMedCrossRef Esaki Y, Hirayama R, Hirokawa K (1990) A comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer 65:2086–2090PubMedCrossRef
7.
go back to reference Hamilton SR, Aaltonen LA (eds) (2000) In: WHO classification of tumors: pathology and genetics of tumors of the digestive system. IARC, Lyon, pp 39–50 Hamilton SR, Aaltonen LA (eds) (2000) In: WHO classification of tumors: pathology and genetics of tumors of the digestive system. IARC, Lyon, pp 39–50
8.
go back to reference Hong RL, Lee WJ, Shun CT, Chu JS, Chen YC (1995) Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas. Oncology 52:334–339PubMedCrossRef Hong RL, Lee WJ, Shun CT, Chu JS, Chen YC (1995) Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas. Oncology 52:334–339PubMedCrossRef
9.
go back to reference Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC (2004) Gastric cancer originating from bone marrow-derived cells. Science 306:1568–1571PubMedCrossRef Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC (2004) Gastric cancer originating from bone marrow-derived cells. Science 306:1568–1571PubMedCrossRef
10.
go back to reference Huang SP, Wu MS, Wang HP, Yang CS, Kuo ML, Lin JT (2002) Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma. J Gastroenterol Hepatol 17:1165–1169PubMedCrossRef Huang SP, Wu MS, Wang HP, Yang CS, Kuo ML, Lin JT (2002) Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma. J Gastroenterol Hepatol 17:1165–1169PubMedCrossRef
11.
go back to reference Kelley JR, Duggan JM (2003) Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56:1–9PubMedCrossRef Kelley JR, Duggan JM (2003) Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56:1–9PubMedCrossRef
12.
go back to reference Kushima R, Hattori T (1993) Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach. J Cancer Res Clin Oncol 120:103–111PubMedCrossRef Kushima R, Hattori T (1993) Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach. J Cancer Res Clin Oncol 120:103–111PubMedCrossRef
13.
go back to reference Kushima R, Vieth M, Borchard F, Stolte M, Mukaisho K, Hattori T (2006) Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer 9:177–184PubMedCrossRef Kushima R, Vieth M, Borchard F, Stolte M, Mukaisho K, Hattori T (2006) Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer 9:177–184PubMedCrossRef
14.
go back to reference Kozuki T, Yao T, Nakamura S, Matsumoto T, Tsuneyoshi M (2002) Differences in p53 and cadherin–catenin complex expression between histological subtypes in diffusely infiltrating gastric carcinoma. Histopathology 41:56–64PubMedCrossRef Kozuki T, Yao T, Nakamura S, Matsumoto T, Tsuneyoshi M (2002) Differences in p53 and cadherin–catenin complex expression between histological subtypes in diffusely infiltrating gastric carcinoma. Histopathology 41:56–64PubMedCrossRef
15.
go back to reference Kumada T, Tsuneyama K, Hatta H, Ishizawa S, Takano Y (2004) Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol 17:1141–1149PubMedCrossRef Kumada T, Tsuneyama K, Hatta H, Ishizawa S, Takano Y (2004) Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol 17:1141–1149PubMedCrossRef
16.
go back to reference Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49PubMed Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49PubMed
17.
go back to reference Li HC, Stoicov C, Rogers AB, Houghton J (2006) Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 12:363–371PubMed Li HC, Stoicov C, Rogers AB, Houghton J (2006) Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 12:363–371PubMed
18.
go back to reference Liu SC (1989) A newly recognized precancerous lesion of the stomach—histopathologic features of globoid dysplasia of human gastric epithelium. Zhonghua Zhong Liu Za Zhi 11:37–40PubMed Liu SC (1989) A newly recognized precancerous lesion of the stomach—histopathologic features of globoid dysplasia of human gastric epithelium. Zhonghua Zhong Liu Za Zhi 11:37–40PubMed
19.
go back to reference Lynch HT, Grady W, Suriano G, Huntsman D (2005) Gastric cancer: new genetic developments. J Surg Oncol 90:114–133PubMedCrossRef Lynch HT, Grady W, Suriano G, Huntsman D (2005) Gastric cancer: new genetic developments. J Surg Oncol 90:114–133PubMedCrossRef
20.
go back to reference Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simões M (2000) Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 190:437–43PubMedCrossRef Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simões M (2000) Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 190:437–43PubMedCrossRef
21.
go back to reference Machado JC, Soares P, Carneiro F, Rocha A, Beck S, Blin N, Berx G, Sobrinho-Simoes M (1999) E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 79:459–465PubMed Machado JC, Soares P, Carneiro F, Rocha A, Beck S, Blin N, Berx G, Sobrinho-Simoes M (1999) E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 79:459–465PubMed
22.
go back to reference Reis CA, David L, Nielsen PA, Clausen H, Mirgorodskaya K, Roepstorff P, Sobrinho-Simões M (1997) Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer 74:112–121PubMedCrossRef Reis CA, David L, Nielsen PA, Clausen H, Mirgorodskaya K, Roepstorff P, Sobrinho-Simões M (1997) Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer 74:112–121PubMedCrossRef
23.
go back to reference Roukos DH, Agnantis NJ, Fatouros M, Kappas AM (2002) Gastric cancer: introduction, pathology, epidemiology. Gastric & Breast Cancer 1:1–3 Roukos DH, Agnantis NJ, Fatouros M, Kappas AM (2002) Gastric cancer: introduction, pathology, epidemiology. Gastric & Breast Cancer 1:1–3
24.
go back to reference Shibata A, Longacre TA, Puligandla B, Parsonnet J, Habel LA (2001) Histological classification of gastric adenocarcinoma for epidemiological research: concordance between pathologists. Cancer Epidemiol Biomarkers Prev 10:75–78PubMed Shibata A, Longacre TA, Puligandla B, Parsonnet J, Habel LA (2001) Histological classification of gastric adenocarcinoma for epidemiological research: concordance between pathologists. Cancer Epidemiol Biomarkers Prev 10:75–78PubMed
25.
go back to reference Sobin LH, Wittekind CH (2002) TNM classification of malignant tumors, 6th edn. John Wiley, New York, pp 55–65 Sobin LH, Wittekind CH (2002) TNM classification of malignant tumors, 6th edn. John Wiley, New York, pp 55–65
26.
go back to reference Stelzner S, Emmrich P (1997) The mixed type in Lauren's classification of gastric carcinoma. Histologic description and biologic behavior. Gen Diagn Pathol 143:39–48PubMed Stelzner S, Emmrich P (1997) The mixed type in Lauren's classification of gastric carcinoma. Histologic description and biologic behavior. Gen Diagn Pathol 143:39–48PubMed
27.
go back to reference Tahara E (2004) Genetic pathways of two types of gastric cancer. IARC Sci Publ 157:327–349PubMed Tahara E (2004) Genetic pathways of two types of gastric cancer. IARC Sci Publ 157:327–349PubMed
28.
go back to reference Zheng HC, Sun JM, Wei ZL, Yang XF, Zhang YC, Xin Y (2003) Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer. World J Gastroenterol 9:1415–1420PubMed Zheng HC, Sun JM, Wei ZL, Yang XF, Zhang YC, Xin Y (2003) Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer. World J Gastroenterol 9:1415–1420PubMed
29.
go back to reference Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, Tsuneyama K, Takano Y (2006a) Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26:3579–3583PubMed Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, Tsuneyama K, Takano Y (2006a) Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26:3579–3583PubMed
30.
go back to reference Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, Tsuneyama K, Takano Y (2007a) Pathobiological characteristics of intestinal- and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol 60:273–277PubMedCrossRef Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, Tsuneyama K, Takano Y (2007a) Pathobiological characteristics of intestinal- and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol 60:273–277PubMedCrossRef
31.
go back to reference Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Tsuneyama K, Masuda S, Takano Y (2007b) Low expression of FHIT and PTEN correlates with malignancy of gastric carcinoma: tissue-array findings. Appl Immunohistochem Mol Morphol 15(4):432–440PubMed Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Tsuneyama K, Masuda S, Takano Y (2007b) Low expression of FHIT and PTEN correlates with malignancy of gastric carcinoma: tissue-array findings. Appl Immunohistochem Mol Morphol 15(4):432–440PubMed
32.
go back to reference Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K, Takano Y (2006d) Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br J Cancer 95:1371–1378PubMedCrossRef Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K, Takano Y (2006d) Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br J Cancer 95:1371–1378PubMedCrossRef
33.
go back to reference Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K, Takano Y (2006b) MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol 132:817–823PubMedCrossRef Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K, Takano Y (2006b) MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol 132:817–823PubMedCrossRef
34.
go back to reference Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Murai Y, Nomoto K, Takano Y (2006c) An immunohistochemical study of p53 and Ki-67 in gastrointestinal adenoma and adenocarcinoma using tissue microarray. Anticancer Res 26:2353–2360PubMed Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Murai Y, Nomoto K, Takano Y (2006c) An immunohistochemical study of p53 and Ki-67 in gastrointestinal adenoma and adenocarcinoma using tissue microarray. Anticancer Res 26:2353–2360PubMed
35.
go back to reference Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Murai Y, Nomoto K, Takano Y (2007c) Maspin expression was involved in colorectal adenoma–adenocarcinoma sequence and liver metastasis of tumors. Anticancer Res 27:259–265PubMed Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Murai Y, Nomoto K, Takano Y (2007c) Maspin expression was involved in colorectal adenoma–adenocarcinoma sequence and liver metastasis of tumors. Anticancer Res 27:259–265PubMed
36.
go back to reference Zheng L, Wang L, Ajani J, Xie K (2004) Molecular basis of gastric cancer development and progression. Gastric Cancer 7:61–77PubMedCrossRef Zheng L, Wang L, Ajani J, Xie K (2004) Molecular basis of gastric cancer development and progression. Gastric Cancer 7:61–77PubMedCrossRef
Metadata
Title
Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas
Authors
Hua-chuan Zheng
Xiao-han Li
Takuo Hara
Shinji Masuda
Xiang-hong Yang
Yi-fu Guan
Yasuo Takano
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 5/2008
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-007-0572-7

Other articles of this Issue 5/2008

Virchows Archiv 5/2008 Go to the issue